Schedule 1 is the latest breakout hit on Steam, an open-world drug empire simulator that’s quickly climbed the charts thanks to its gritty gameplay and tongue-in-cheek humor. Just days after its ...

Novo Nordisk is betting on the future with a $2-billion deal to buy rights to a Chinese obesity drug. But investors remain unimpressed.

The general mood among these heavyweight investors is divided, with 44% leaning bullish and 33% bearish. Among these notable options, 5 are puts, totaling $256,004, and 4 are calls, amounting to ...